Home › India board rules against Bayer in cancer drug patent case
 

Keywords :   


India board rules against Bayer in cancer drug patent case

2013-03-04 18:53:06| Chemicals - Topix.net

An Indian patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.

Tags: case board rules india

Category:Chemicals

Latest from this category

All news
25.11Axalta Wins Another Distinguished R&D 100 Award for Innovation
25.11Dunn-Edwards CEO Karl Altergott to Retire, COO Monte Lewis is Successor
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
Chemicals »
25.11 Masego Studying Abroad: Extended Stay LP
25.11Jack Bunny!!
25.11Big Daddy Kane - Raw ()
25.11 e 028/088
25.11 M4A1 MOD3
25.11 CDAriana Grande
25.11
25.11SD8(/)
More »